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Overview 
Drivers of change in public & population health 
Laboratory roles in next-gen public health 
Making the case for laboratory value and ROI 
WHO 2010 
Failures in population health 
 
 
Failures in population health 
Commonwealth Fund 2012 
Premature Deaths per 100,000 Residents 
Drivers of population health failures 
Schroeder SA. N Engl J Med 2007;357:1221-1228 
Public health’s role in population health: 
Optimization  
How to optimally deploy a diverse collection of 
responsibilities, resources, actors & expectations?  
  
– Epidemiologic surveillance & investigation 
– Community health assessment & planning 
– Communicable disease control 
– Chronic disease and injury prevention 
– Health education and communication 
– Environmental health monitoring and assessment 
– Enforcement of health laws and regulations 
– Inspection and licensing 
– Inform, advise, and assist school-based, worksite-based, and 
community-based health programming 
…and roles in assuring access to medical care 
Pressures for change in U.S. public health 
Next Generation 
Population Health 
Improvement 
Learning how to succeed with  
population health strategies 
Designed to achieve large-scale health 
improvement: neighborhood, community, state 
Target fundamental and often multiple  
determinants of health 
Mobilize the collective actions of multiple 
stakeholders in government & private sector  
 - Usual and unusual suspects 
 - Infrastructure requirements 
 Mays GP.  Governmental public health and the economics of adaptation to population health 
strategies.  IOM Population Health Roundtable Discussion Paper.  February 2014.   
Incentive compatibility → public goods 
Concentrated costs & diffuse benefits 
Time lags: costs vs. improvements 
Uncertainties about what works 
Gaps and asymmetries in information 
Difficulties measuring progress 
Weak and variable institutions & infrastructure 
Imbalance: resources vs. needs 
Stability & sustainability of funding 
Overcoming collective action problems 
Ostrom E.  1994 
Standardization vs. Customization  
in public health delivery 
Standardization 
▼Harmful variation 
▼Wasteful variation 
▼Inequitable variation 
▼Race to the bottom 
▲Network externalities: 
interoperability/coordination 
Customization 
▲Target resources to 
greatest needs/risks 
▲ Tailor approaches to 
values & preferences of 
stakeholders 
▲ Deploy unique resources 
& skills to their best 
purposes  
Effectiveness 
Efficiency 
Equity 
Roles for research and innovation 
Patient Protection and Affordable Care Act of 2010 
Toward a “rapid-learning system” in public health 
Green SM et al. Ann Intern Med. 2012;157(3):207-210 
Laboratory roles in next generation 
public health 
Expanding volume & quality of information 
Accelerating timeliness of testing & dissemination 
Examining cost/benefit trade-offs of new testing 
Innovating information transmission/exchange 
Harvesting laboratory information flows for research 
Using real-time laboratory information to target and 
tailor public health interventions 
Enhancing laboratory capacity 
requires knowledge of value 
Health AND economic returns 
Information production AND application 
Multiple users of laboratory information 
− Public health agencies 
− Health care providers 
− Other regulatory bodies 
− Industry 
− Individuals/families/communities 
Key concept: value of information (VOI) 
− How does new information change decision-making & action 
Pathways for research and learning 
about public health value 
Descriptive 
 
 
Inferential 
 
 
Translational 
 Measuring practice & performance 
 
 Detecting variation in practice 
  
 Examining determinants of variation 
   – Organization      – Law & policy 
   – Financing    – Information 
   – Workforce   – Preference 
 
 Determining consequences of variation 
   – Health outcomes  – Medical care use 
 – Economic outcomes – Disparities 
 
 Testing strategies to reduce harmful, 
  wasteful, & inequitable variation  
  in practice and outcomes 
Variation in Public Health Practice in the U.S. 
Delivery of IOM recommended public health activities 
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National Longitudinal Survey of Public Health Systems, 2012 
Variation in Public Health Practice in the U.S. 
Delivery of IOM recommended public health activities, 2012 
National Longitudinal Survey of Public Health Systems, 2012 
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National Longitudinal Survey of Public Health Systems, 2012 
National Longitudinal Survey of Public Health Systems, 2012 
Inter-organizational relationships  
in public health delivery 
Economics in public health variation 
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Public health agency expenditures per capita, 2010 
Gini = 0.485 
Economics in public health variation 
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Change in per-capita expenditures ($), 1993-2010 
62% 
growth 
38% 
decline 
Mortality reductions attributable to local 
public health spending, 1993-2008 
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Hierarchical regression estimates with instrumental variables to correct for selection 
and unmeasured confounding 
Mays et al. 2011 
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Mays et al. 2009, 2013 
Medical cost offsets attributable to investments 
in public health delivery, 1993-2008 
For every $10 of public health spending, ≈$9 are recovered  
in lower medical care spending over 15 years 
Estimating value for public health 
spending 
1.2% increase in public health spending in the 
average community over 10 years: 
 
Public health cost  $7.2M 
Medical cost offset        -$6.3M  (Medicare only) 
Deaths averted           175.8 
Life years gained        1758 
Net cost/LY         $546 
 
Applying a value lens to laboratories 
Identify the value chain 
information → action  → outcome 
Consider the roles of information volume/ 
completeness, quality, and timeliness 
Identify the costs of information production 
Use variation in information production to model 
downstream effects on actions and outcomes 
Evaluate the value of effects using health and/or 
monetary metrics: e.g. cases detected, cases 
prevented, QALYs saved, costs avoided 
Example: detecting food-borne illness 
The New York Times ©2009 
Lurie et al. 2004 
Example: timeliness in case report response  
Multi-Network Practice and Outcome 
Variation Examination Study (MPROVE) 
 Identify service delivery measures for selected, high-value 
public health services 
 Create a registry of measures collected consistently across 
local communities   
 Profile geographic variation in the delivery of selected public 
health services across local communities 
 Decompose variation into attributable components:  
– need-sensitive or preference-sensitive factors 
– supply-sensitive factors 
 Examine associations between service delivery & outcomes 
 
28 
Participating MPROVE networks 
29 
Network 
State 
Agencies 
Local 
Agencies 
Academic 
Units Other Total 
Lead 
Institution 
CO 1 55 2 15 73 Association 
FL 1 67 3 3 74 Local agency 
MN 1 75 1 1 78 State agency 
WA 1 36 2 1 40 Local agency 
NJ 1 100 2 1 104 Academic 
TN 1 16 2 1 20 Academic 
Total 6 349 12 22 389 
MPROVE Measure Domains 
 Communicable disease control 
 Chronic disease prevention 
 Environmental health protection 
 
 
30 
MPROVE Measurement Dimensions 
 Availability/scope: are selected services/activities 
produced or performed by the public health agency or 
delivery system  
 Volume/intensity: absolute or relative frequency of 
service delivery over a given unit of time 
 Capacity: ratio of inputs to size of the relevant target 
population or risk (e.g. sanitarians per 1000 septic tanks, 
food safety inspectors per 1000 licensed food vendors)   
 Reach: percent of the target population reached by the 
activity 
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MPROVE Measurement Dimensions 
 Quality-Appropriateness: Does the public health agency and/or system act 
based on objectively measured health needs and risk profiles of the population 
served?  What is the degree of concordance between a community’s 
documented health needs/risks and the scope of public health activities 
performed by the public health agency or the system as a whole?  
 Quality-Effectiveness/Fidelity: Does the public health agency and/or system 
implement its activities based on available scientific knowledge and fidelity to 
evidence-based guidelines?  To what extent are programs and services 
concordant with evidence-based guidelines and professional consensus 
standards? 
 Quality-Timeliness:  Are public health activities implemented at the appropriate 
points in time to maximize health protection and minimize the risk of disease 
transmission or injury?    
 Quality-Community Centeredness/Engagement: To what extent are relevant 
stakeholders engaged in planning, priority-setting, selection, and implementation 
of public health activities undertaken by the public health agency and/or system?  
To what extent are public health activities tailored appropriately to at-risk 
population groups based on the groups’ values, preferences, needs, knowledge, 
skills, and resources?   
 
MPROVE Measurement Dimensions 
 Quality-Efficiency:  To what extent are public health 
activities implemented in ways that optimize the use of 
financial and human resources?  To what extent do 
implementation processes avoid waste and delays in 
service?  To what extent do the benefits of public health 
activities justify their costs?   
 Quality-Equity:  Are there disparities in the reach of 
public health activities to different population sub-groups 
defined by personal characteristics such as race, 
ethnicity, geography, or socio-economic status?  Are 
there disparities in effectiveness, timeliness, community-
centeredness, and/or efficiency?  
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Multi-network Practice and Outcome Variation Examination Study (MPROVE) 2014 
Example: timeliness of enteric disease 
investigations  
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State public health research network  
The push and pull of laboratory ROI 
ROI is contingent on the flow of information into 
and out of the laboratory 
− The right tests in the right circumstances  
at the right time 
− Accurate specimen collection & transport 
− Timely access and use of test results 
Labs can play important roles in push and pull 
− Monitor & feedback on submission volume & 
quality 
− Reminders & prompts 
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Considering economies of scale and scope 
Common 
questions 
of interest 
Rigorous 
research 
methods 
Data 
exchange 
Analysis & 
interpretation 
Translation 
& 
application 
PBRNs as Mechanisms for Learning 
Engaged  
practice 
settings 
Research 
partner 
Identify 
Apply 
Public Health PBRNs 
First cohort (December 2008 start-up)
Second cohort (January 2010 start-up)
Affiliate/Emerging PBRNs (2011-14)
(    New in 2013) 
Laboratories and learning systems in public health 
Green SM et al. Ann Intern Med. 2012;157(3):207-210 
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